This award recognises the pharma or large cap company that has demonstrated a superior excellence in strategy, process, focus and execution to create significant value for patients, shareholders and investors, employees and the broader community.
Judges paid particular attention to:
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years.
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world's leading biotech companies, with multiple products on the market and a promising development pipeline.